Menopause, What HRT Actually Does & What It Means for APOE4 Carriers
Part 1: breast-cancer risk, pills vs patches, and the menopause questions APOE4 carriers asked.
Key takeaways · TL;DR
Part 1: breast-cancer risk, pills vs patches, and the menopause questions APOE4 carriers asked.
Hi Phoenix friend,
80% of the Phoenix community is female, so I wanted a better answer than either "HRT is dangerous" or "HRT is perfectly safe."
This is part of the August monthly theme we run in the community about HRT, Hormones and Menopause.
If you are interested in submitting your questions for these types of interviews, join the Phoenix Community.
For more than 20 years, one number has shaped the hormone conversation.
26%.
That was the relative increase in invasive breast cancer reported in the combined-hormone arm of the 2002 Women's Health Initiative.
The absolute numbers were 38 cases per 10,000 person-years in the hormone group and 30 in the placebo group.
Eight additional cases per 10,000 person-years.
[Study: Rossouw et al., 2002]
That does not mean hormone therapy is right for everyone.
It means the headline was not the whole decision.
And in February 2026, the FDA approved updated labeling for several menopause hormone-therapy products. The cardiovascular disease, breast cancer, and probable dementia statements came out of the boxed warning, while important risk information remained elsewhere in the labels.
[FDA, 2026]
Most women never heard that update.
So I sat down with Steve Goldring, RPh, known as The Hormone Pharmacist.
Steve spent more than 25 years as a compounding pharmacist. He has heard the same questions across the counter again and again:
Should I take hormones?
Is a patch safer than a pill?
What if progesterone makes me feel worse?
What if I have no hot flashes, but my levels are low?
What changes if I carry APOE4?
Every question in this Q&A came from a member.
What Part 1 covers
1. What the 2002 study actually tested
The Women's Health Initiative did not test every form of hormone therapy used today.
Steve explains the specific estrogen-plus-progestin combination, the age of the participants, the difference between relative and absolute risk, and why one result became a global headline.
2. The whole hormone menu
Pill. Patch. Gel. Cream. Vaginal estrogen. Pellet.
Each route has advantages and drawbacks. Steve does not pretend there is one default answer for everyone.
The most useful parts of the conversation are practical: what happens when a patch falls off, why a dose can feel different near patch-change day, and why the route through the liver changes some effects.
3. Progesterone and sleep
Steve explains why oral micronized progesterone affects sleep differently from vaginal or transdermal progesterone.
We also cover the smaller group of women who feel worse on progesterone, not better, and the questions worth taking to a clinician.
4. Symptoms versus longer-term health
Feeling fine is not the same as having answered every health question.
The episode separates symptom relief from conversations about bone, cardiovascular, metabolic, and cognitive health.
The APOE4 evidence is not settled enough to turn hormone therapy into an Alzheimer's-prevention strategy. That is exactly why APOE4 carriers need a better conversation, not a slogan.
[Study: Melville et al., 2025]
The line that stayed with me
Steve put the decision plainly:
"You are not choosing between risk and zero risk. You are choosing which risks you carry."
That is the point of Part 1.
Not "everyone should take HRT."
Not "nobody should take HRT."
A clearer map of the options, the evidence, and the questions you can take into your next appointment.
Part 2 (publishing in a week) goes further into whether it is ever too late to start, how to get taken seriously by a dismissive clinician, hormone testing, compounding pharmacies, and the questions that still do not have clean answers.
Cheers,
Kevin
P.S. If like for this episodes you want a question included in a future Q&A, post it inside the Phoenix community. The member questions are what make these conversations useful.
Sources
This conversation is educational and does not replace care from a clinician who knows your medical history.
Most Newsletters? One-way street.
How boring…
This is the Phoenix Community. So let's make it a two-way street.
Got a question? Feedback?
Hit reply. I read every single one.
